Tenderwize
Zurück zur Suche

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ibuprofen, ATC M01AE01

80/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

80 / 100

Komplexität

20 / 100

Risikofaktoren

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount contracts for Ibuprofen (ATC M01AE01) drugs under SGB V.
  • Open house model: all interested pharmaceutical companies can join without selection.
Vollständige Zusammenfassung anzeigen

The AOK Rheinland-Pfalz/Saarland offers non-exclusive drug discount contracts (Open House) for the active ingredient Ibuprofen (ATC M01AE01) under German social law (SGB V). All pharmaceutical companies with authorized and marketable Ibuprofen products in Germany can join without selection. Contracts have a maximum duration of 24 months, starting from June 2025. The notice is published voluntarily and does not constitute an EU procurement. Paper-based submission is required; electronic submission is not allowed. The tender has no estimated value and no specific award criteria. Note: The structured data indicates EU funding, but the XML notice explicitly states no EU funding. This analysis is based on the structured data and XML notice only; no separate procurement documents were analyzed.

Risiken

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

  • Only authorized and marketable drugs in Germany (proof via Lauer-Taxe listing or AMIce database) are eligible.

Administrative

  • Paper-based submission required; electronic submission is not allowed.
  • Submission in German language only (as per notice language).

Zuschlagskriterien

Lot 1

No award criteria; this is an open-house model with no selection.

Auftraggeber

Lose (1)

LOT-0001

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

Non-exclusive discount contracts for Ibuprofen drugs under German SGB V. Open to all pharmaceutical companies with authorized and marketable Ibuprofen products. Contracts last up to 24 months, with enrollment possible at the start of each month. All contracts end simultaneously 24 months after the earliest contract start date (June 2025). The buyer may replace open-house contracts with exclusive contracts via tender at any time.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria; this is an open-house model with no selection.

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
238514-2025

Dokumente (1)

Ähnliche Ausschreibungen